Table 2. Safety index of the standard and intensive treatment groups $\left(\overline{\chi }\pm s\right)$.

	Baseline			6 months after RDN
	Standard treatment	Intensive treatment	P	Standard treatment	Intensive treatment	P
Creatinine (mg/dL)	102.1 ± 47.9	135.7 ± 193.5	.455	104.9 ± 80.8	170.0 ± 243.0	.291
eGFR [mL/(min/1.73m2)]	73.6 ± 24.1	71.8 ± 28.0	.829	82.6 ± 29.6	62.5 ± 28.6	.057
Glucose (mg/dL)	6.5 ± 2.4	5.5 ± 2.0	.135	7.8 ± 5.6	5.3 ± 2.3	.115
AST (U/L)	22.2 ± 9.2	36.9 ± 15.1	.339	18.6 ± 8.5	19.1 ± 7.4	.875
ALT (U/L)	20.5 ± 14.32	38.6 ± 18.8	.351	15.8 ± 8.6	15.4 ± 10.9	.929
Hb (g/L)	133.3 ± 16.2	141.1 ± 26.5	.260	130.2 ± 22.6	131.5 ± 23.8	.883
BNP (pg/mL)	596.9 ± 220.2	422.3 ± 146.7	.506	281.0 ± 116.7	184.8 ± 62.1	.457

Notes.

Abbreviations

AST

aspartate aminotransferase

ALT

Alanine aminotransferase

Hb

hemoglobin

BNP

Brain natriuretic peptide